Indiana University Hospital has become the first clinical site in the U.S. to begin using Philips' top-of-the-line Brilliance CT 40-slice system. Hospital staff are putting the system through its paces to evaluate patients and identify disease in a range
Indiana University Hospital has become the first clinical site in the U.S. to begin using Philips' top-of-the-line Brilliance CT 40-slice system. Hospital staff are putting the system through its paces to evaluate patients and identify disease in a range of dynamic and static clinical applications. Among the primary interests are cardiac studies, as well as those of the chest and abdomen. Scanning covers 40 mm with each turn of the gantry, traversing the lungs in four seconds, and the abdomen and pelvis in nine seconds. A whole-body CT angiogram takes about 15 seconds. Indiana University Hospital has been a test bed for advanced CT technologies since Picker International began evaluating its scanners there some 16 years ago. Philips acquired Picker International in 2001. The Brilliance 40-slice CT was formally unveiled at the 2003 RSNA meeting (SCAN 11/26/03).
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.